Health Catalyst (NASDAQ:HCAT) Announces Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Health Catalyst (NASDAQ:HCAT) issued its earnings results on Monday. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.01 by $0.01, FiscalAI reports. Health Catalyst had a negative net margin of 57.20% and a negative return on equity of 4.30%. The business had revenue of $70.76 million for the quarter, compared to analysts’ expectations of $69.24 million.

Health Catalyst Price Performance

Shares of Health Catalyst stock traded down $0.14 during trading on Monday, hitting $1.38. The stock had a trading volume of 281,362 shares, compared to its average volume of 763,214. The firm has a market cap of $101.55 million, a price-to-earnings ratio of -0.54 and a beta of 1.63. Health Catalyst has a 12 month low of $0.96 and a 12 month high of $4.74. The business’s 50-day moving average is $1.37 and its 200 day moving average is $2.08. The company has a current ratio of 1.89, a quick ratio of 1.89 and a debt-to-equity ratio of 0.62.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. First Light Asset Management LLC increased its holdings in shares of Health Catalyst by 17.2% in the second quarter. First Light Asset Management LLC now owns 12,230,181 shares of the company’s stock worth $46,108,000 after purchasing an additional 1,793,374 shares during the period. Vanguard Group Inc. increased its holdings in shares of Health Catalyst by 2.9% in the third quarter. Vanguard Group Inc. now owns 4,295,691 shares of the company’s stock worth $12,243,000 after purchasing an additional 119,117 shares during the period. Geode Capital Management LLC increased its holdings in shares of Health Catalyst by 11.4% in the second quarter. Geode Capital Management LLC now owns 1,662,455 shares of the company’s stock worth $6,269,000 after purchasing an additional 169,580 shares during the period. Millennium Management LLC increased its holdings in shares of Health Catalyst by 2,513.3% in the third quarter. Millennium Management LLC now owns 1,589,536 shares of the company’s stock worth $4,530,000 after purchasing an additional 1,528,710 shares during the period. Finally, State Street Corp increased its holdings in shares of Health Catalyst by 4.3% in the fourth quarter. State Street Corp now owns 1,327,922 shares of the company’s stock worth $3,174,000 after purchasing an additional 54,168 shares during the period. Institutional investors own 85.00% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on HCAT. Weiss Ratings reissued a “sell (e+)” rating on shares of Health Catalyst in a report on Friday, March 27th. Raymond James Financial set a $3.00 target price on shares of Health Catalyst in a report on Friday, March 13th. Stifel Nicolaus lowered their target price on shares of Health Catalyst from $3.75 to $2.00 and set a “hold” rating on the stock in a report on Friday, March 13th. Canaccord Genuity Group lowered their target price on shares of Health Catalyst from $5.00 to $2.00 and set a “buy” rating on the stock in a report on Friday, March 13th. Finally, Citigroup lowered their target price on shares of Health Catalyst from $2.75 to $1.75 and set a “neutral” rating on the stock in a report on Friday, March 13th. Four research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $2.80.

About Health Catalyst

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.